0% found this document useful (0 votes)
54 views19 pages

Hemostasis and Bleeding Disorders Explained

The document discusses hemostasis and bleeding disorders. It describes the steps of hemostasis including vasoconstriction, platelet plug formation, and coagulation. It then discusses specific bleeding disorders like immune thrombocytopenia, hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, and disseminated intravascular coagulation.

Uploaded by

Gaurav Thapa
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
54 views19 pages

Hemostasis and Bleeding Disorders Explained

The document discusses hemostasis and bleeding disorders. It describes the steps of hemostasis including vasoconstriction, platelet plug formation, and coagulation. It then discusses specific bleeding disorders like immune thrombocytopenia, hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, and disseminated intravascular coagulation.

Uploaded by

Gaurav Thapa
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

AfraTafreeh.

com

HEMOSTASIS

Steps of hemostasis: As injury occurs following steps come in role

1. Vasoconstriction
2. Formation of platelet plug ( primary hemostatic plug)
3. Coagulation cascade ( clot formation )

HOW PLATELET FUNCTIONS ?

After injury →
1. Platelet adhesion:
 Platelets via gpIb/ IX binds with von Wilibrand factor (Vwf) present on
endothelial cells.

2. Platelet activation :
 Change in shape of platelets
 Release of contents from platelets

Thromboxane A2 [IX A2]

ADP (As a result of this release there is activation of


coagulation cascade )

3. Platelet aggregation:
 Multiple platelets arrive forming a hemostatic plug

1
AfraTafreeh.com
 Binding between two platelets is aided by another receptors
gp2b/3a

Activation of coagulation cascade

Thrombin


AfraTafreeh.com

Fibrin

This fibrin makes the clot firm/stable


[Forms the meshwork between platelets ]
BLEEDING DISORDERS

BLEEDING
DISORDERS

Can be due to Due to platelet Due to


vascular causes causes coagulation defect

 Due to vascular causes:


They are said to be diagnosis of exclusions i.e we think about vascular causes
after ruling out all other causes because in vascular causes
BT , CT ,PT , Aptt are normal.
 Due to platelet causes:

It can be due to defect in number.

Normal platelet count – (1.5-4 lac/mm³).


AfraTafreeh.com

Decreased platelet count(thromboctyopenia

MEGAKARYOCYTIC
THROMBOCYTOPENIA AMEGAKARYOCYTIC
↓ THROMBOCYTOPENIA
marrow eill try to compensate ↓
and there will be increase in no rise in megakaryocyte in seen
megakaryocytes.

1
AfraTafreeh.com

 CAUSES OF MEGAKARYOCYTIC THROMBOCYTOPENIA


IMMUNE
 ITP
 SLE
 Dengue
 Drugs

NON IMMUNE

 DIC
 HUS
 TTP
 CAUSES OF AMEGAKARYOCYTIC THROMNOCYTOPENIA
 Aplastic anemia
 Bone marrow fibrosis
 Vitamin B12,folic acid deficiency
 Drugs.

2
IMMUNE THROMBOCYTOPRNIC PURPURA
 TYPE 2 Hypersensitivity reaction (antibody me diated)

Antibodies like IgG [opsonins] will attack platelets

These platelets coated by antibodies while passing through spleen undergo


phagocytosis as they are opsonized

Therefore, decrease seen in platelet count

 CLINCAL FEATURES (seen due to superficial tissue bleeding)


 Petechiae
 Purpura
 Gum bleeding
 Hemorrhagic bulla
AfraTafreeh.com

TYPES OF ITP

ACUTE CHRONIC

ACUTE

 Sudden onset
 Resolve within 6 months
 More severe
 History: child with viral infection
 Platelet count<50,000
 Treatment –symptomatic

1
AfraTafreeh.com

CHRONIC

 Delayed onset
 Takes 6 months
 Less severe
 Seen in adults and no viral infection
 Platelet count→ 3,000-5,000
 Treatment – steroids
 DIAGNOSIS OF ITP:
 Diagnosis of exclusion
 Platelet count decreased
 BT increased
 PT and aPTT are normal as there is no change in coagulation pat hway
 COOMB`s test →positive
 Bone marrow examination → increase in megakaryocytes

2
ANGIOPATHIC HAEMOLYTIC ANEMIA
 There in anemia due to hemolysis which in turn is because of blood vessels.
 It can involve large blood vessels or small blood vessels.

ANGIOPATHIC HAEMOLYTIC ANEMIA

MAHA(Macroangiopathi MIHA(Microangiopathic
c haemolytic anemia) haemolytic anemia)

 MACROANGIOPATHIC HAEMOLYTIC ANEMIA


(involves large blood vessels )
EXAMPLE:
AfraTafreeh.com
1. Prosthetic heart valve causes MAHA
(Aortic valves>mitral valves )
2. Aortic stenosis
[increased pressure through valves

RBCs will start breaking resulting in MAHA ]
3. Vascular grafting
4. Cavernous hemangioma

 MICROANGIOPATHIC HAMEOLYTIC ANEMIA


(involves small blood vessels)
Causes:
1. DIC
2. HUS
3. TTP
4. Malignant hypertension
5. March haemoglobulinemia

NOTE: Causes of both MAHA and MIHA will result in fragmented RBCs also known as

1
SCHISTOCYTES .
AfraTafreeh.com

HEMOLYTIC UREMIC SYNDROME

 Non-immune megakaryocytic thrombocytopenia


 It is of 2 types:
o Typical HUS:
 Will give typical history of a child with acute gastro -enteritis
which is caused by E. Cali [O157/H7] and Shigella [toxin], Both will
result in formation of platelet rich Thrombi
o Atypical HUS:
 Defect in complement proteins Factor H/ Factor I / CD46
 Or due to drugs:
 Mitomycin
 Ticlopidine
also result in Platelet rich Thrombi
 Now as there is thrombi in BV, the RBCs on striking with thrombi underg oes
hemolysis that is microangiopathic hemolytic anemia occurs

 4]
 As platelets are consumed in thrombi formation , platelet count decreases 
Thrombocytopenia
 Platelet rich thrombi can go & Block renal vessels & cause renal failure
 Thus in HUS there is Triad of:
o Macroangiopathic hemolytic anemia
o Thrombocytopenia
o Renal Failure
 C/Fs:
o Petechiae / Purpura

1
o Bloody diarrhea
 Diagnosis:
o Decreased Platelet Count
o BT increased
o PT normal
o aPTT normal
 Thrombotic Thrombocytopenia Purpura [TTP]:
o Liver produces a protein, Protease ADAM TS 13 which breaks VWF
polymers into VWF monomers, If there is decrease in ADAM TS 13, due
to congenital deficiency  condition is called UPSHAW SCHULMANN
Syndrome and due to Acquired conditions seen in Autoimmune
conditions
o As ADAM TS 13 decreases  VWF Polymers will not convert into VWF
monomers  Aggregate Platelets:
 Thrombosis
 Decreased Platelet Count
 C/Fs:
o MIHA
o Decreased Platelet Count
AfraTafreeh.com
o Renal failure
o Fever
o CNS Involvement
 Treatment [For acquired TTP]: Plasmapheresis

2
AfraTafreeh.com

DISSEMINATED INTRAVASCULAR
COAGULATION [DIC]

 Consumptive Coagulopathy
 Causes:
o Obstetric Causes:
 Retained placenta
 Retained product of conception
 Amniotic fluid embolism
o Infection
o Cancers: All cancers where mucin can be liberated
 AMLM 3
 Gastric
 Colonic
 Pancreatic
o Burns / Trauma
 Note: Obstetric causes, Infection, Cancers  cause Endothelial cell
damage/injury  Activation of Intrinsic Pathway of Coagulation
Burns / Trauma  Release of Tissue Factors  Activation of Extrinsic
Pathway
 By activation of extrinsic, intrinsic pathway thrombi formation occurs; this
process will go on & on leading to consumptive coagulopathy [that is all
coagulation factors get consumed]  Resulting in BLEEDING
 Thrombi will activate fibrinolytic pathway [that is activate plasmin] therefore
clot will break resulting in bleeding

1
 Within BV, RBCs will strike with thrombi & form SCHISTOCYTES / Fragmented
RBCs
 Diagnosis:
o ↓ Hb [Anemia]
o ↓ Platelet count
AfraTafreeh.com
o Peripheral smear  Schistocytes
o Bleeding time ↑
o PT ↑
o aPTT ↑ [as both intrinsic, extrinsic pathway are affected]
o D-DIMER + [Activation of fibrinolytic pathway; breakage of
fibrin/thrombus forming by product D -DIMER
 C/Fs: affects / blacks BVs of
o CNS [Most commonly]
o Heart
o Lung
o Kidney [Acute Tubular Necrosis (ATN)]
o Adrenal Gland [If there is meningococci infection Hemorrhage occurs;
Waterhouse Freidrichson syndrome]

 Treatment: Treat the underlying cause

2
AfraTafreeh.com

DEFECT IN FUNCTION

 Defect in G p IB/ IX receptor  Bernard Soullier Syndrome  Shows +nce of


big/giant Platelets
 Defects in G p IIB/IIIa receptor  Glanzmann Thrombasthenia
 Defect in VWF  Von Willibrand Disease

1
CLOTTING DISORDERS

 HEMOPHILIA:
o A: Factor VIII deficiency
o B: Factor IX deficiency [Christmas Disease]
o C: Factor Eleven deficiency
o Para hemophilia: Factor V deficiency
 Common C/Fs:
o Deep tissue bleed
o Hemarthrosis
o Organ bleeding
o Intracranial bleeding [most dangerous]
o Bleeding after Trauma
o Example : Tooth Extraction Circumcision

AfraTafreeh.com

1
AfraTafreeh.com

8.9 HEMOPHILIA A

 Deficiency of Factor VIII


 Synthesis : 2 sources –
o From Liver:
 Kuffer cells
 Sinusoidal endothelial cells
o From Kidney –
 Tubular epithelial cells
 Deficiency:
o 90% cases show Quantitative defect
o 10% cases show Qualitative defect
 Effect:
o Intrinsic Pathway is affected
 Diagnosis:
o Platelet Count – Normal
o BT – Normal
o PT – Normal
o aPTT – Increased [Associated with intrinsic pathway]
o Factor VIII assay  Based on this assay:
 MILD  6-50% of functional activity is +nt
 MODERATE  1-5% of functional activity +nt
 SEVERE  <1%
 Rx:
o Mild Deficiency  Desmopressin; as it will release factor VIII from
liver endothelial cells
o Severe Deficiency  Recombinant factor VIII [HUMATE]
o We can manage the pt. till the use of H UMATE by using Blood
Transfusion process that is CRYOPRECIPITATE [Blood product rich in
F.VIII]
HEMOPHILIA B

 Deficiency of Factor IX
 Christmas disease
 Involves Intrinsic Pathway
 Diagnosis:
o Platelet Count – Normal
o BT – Normal
o PT – Normal
o aPTT – increases
o Factor IX assay
 Tt:
o Recombinant Factor IX
o Blood Transfusion = Fresh Frozen Plasma [FFP]

AfraTafreeh.com

1
AfraTafreeh.com

FACTOR INHIBITORS

 There are some inhibitors in the form of antibodies which inhibit clotting
factors; are called factor inhibitors
 Such Abs are formed in, example:
o Pregnancy
o Autoimmune disease
 Such individuals have risen in aPTT
 Note: Isolated ↑↑ aPPT can occur in [when all other timings are normal]:
o Heparin Toxicity
o Factor Deficiency or Factor Inhibitor
1. Therefore treat sample with heparinase; if aPTT becomes normal then
diagnosis is Heparin Toxicity
2. Mixing Studies: Take pt. sample & control sample & mix them in 1:1  Repeat
aPTT:
a. Normal aPTT:
i. Diagnosis = Factor Deficiency [because control sample provided
deficient factor which corrected the aPTT]
b. Rise in aPTT:
i. Diagnosis = Factor inhibitor

1
VON WILILBRAND DISEASE

 Source of VWF:
o Endothelial cells [WIEIBEL PALADE]  which have P selectin VWF
o Megakaryocytes
o Liver
 Functions of VWF:
o Carrier of factor VIII:
 Therefore, if factor VIII is bounded with VWF then it’s t 1 / 2 = 12
hours
 If factor VIII is free, then its t 1 / 2 = 2.4 hours
o Helps in platelet adhesion
 Deficiency of vWF:
 As t 1 / 2 of factor VIII decreases therefore, deficiency of VWF
will affect the intrinsic pathway, PT  Normal, aPTT 
Increases
 As platelet adhesion will decrease therefore, BT  Increases,
Platelet count  Normal
AfraTafreeh.com
 VWD is of 3 types:
o Type I:
 AD
 Quantitative defect
 Most common VWD
o Type II:
 AD
 Qualitative defect
 Subtypes are, IIA [most common type II], IIB, IIC, IID
o Type II:
 AR
 Quantitative defect
 Most severe
 C/Fs:
o Mucosal bleeds [Therefore, more towards Platelet disorders than
Coagulation disorders]
 Diagnosis:
o Platelet count – Normal

1
AfraTafreeh.com

o BT increases
o PT normal
o aPTT increases
o RISTOCETIN AGGREGATION TEST
 RISTOCETIN - A chemical that promotes attachment of VWF
with G p Ib/IX
 We take formalin fixed platelets to which RISTOCETIN is added
+ Patient sample
 If VWF is +nt in pt. sample then in +nce of RISTICETIN it will
bind to G p Ib/IX of formalin fixed platelets
 Therefore, Formalin fixed platelets + RISTOCETIN + PATIENT
SAMPLE 
 +ve Aggregation: tested on a machine called
aggregometer  the sample is normal
 -ve Aggregation: Von Willebrand Disease
 t
T :
o Mild deficiency  Desmopressin
o Severe deficiency  Cryoprecipitate

You might also like